↓ Skip to main content

Dove Medical Press

Article Metrics

Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease

Overview of attention for article published in International Journal of Chronic Obstructive Pulmonary Disease, September 2012
Altmetric Badge

About this Attention Score

  • Average Attention Score compared to outputs of the same age
  • Above-average Attention Score compared to outputs of the same age and source (55th percentile)

Mentioned by

twitter
6 tweeters

Citations

dimensions_citation
54 Dimensions

Readers on

mendeley
111 Mendeley
Title
Geroprotectors as a novel therapeutic strategy for COPD, an accelerating aging disease
Published in
International Journal of Chronic Obstructive Pulmonary Disease, September 2012
DOI 10.2147/copd.s28250
Pubmed ID
Authors

Kazuhiro Ito, Colley, Mercado

Abstract

Chronic obstructive pulmonary disease (COPD) progresses very slowly and the majority of patients are therefore elderly. COPD is characterized by an abnormal persistent inflammatory response to noxious environmental stimuli and there are increasing evidences for a close relationship between premature aging and chronic inflammatory diseases. Thus, COPD is considered to be a disease of an accelerating aging. In this review, we collected the evidence for roles of aging on pathogenesis of COPD and considered future therapeutic strategy for COPD based on this senescence hypothesis. Since calorie restriction has been proved to extend lifespan, many efforts were made to clarify the molecular mechanism of aging. Aging is defined as the progressive decline of homeostasis that occurs after the reproductive phase of life is complete, leading to an increasing risk of disease or death due to impaired DNA repair after damage by oxidative stress or telomere shortening as a result of repeated cell division. During aging, pulmonary function progressively deteriorates; innate immunity is impaired and pulmonary inflammation increases, accompanied by structural changes, such as an enlargement of airspaces. Noxious environmental gases, such as cigarette smoke, may worsen these aging-related events in the lung or accelerate aging of the lung due to reduction in anti-aging molecules and/or stimulation of aging molecules. Aging signaling are complex but conserved in divert species, such as worm, fruit fry, rodent and humans. Especially the insulin like growth factor (IGF-1) signaling was well documented. Geroprotectors are therapeutics that affect the root cause of aging and age-related diseases, and thus prolong the life-span of animals. Most of geroprotectors such as melatonin, metformin, rapamycin and resveratrol are anti-oxidant or anti-aging molecule regulators. Therefore, geroprotection for the lung might be an attractive approach for the treatment of COPD by preventing premature aging of lung.

Twitter Demographics

The data shown below were collected from the profiles of 6 tweeters who shared this research output. Click here to find out more about how the information was compiled.

Mendeley readers

The data shown below were compiled from readership statistics for 111 Mendeley readers of this research output. Click here to see the associated Mendeley record.

Geographical breakdown

Country Count As %
United States 2 2%
United Kingdom 1 <1%
France 1 <1%
Spain 1 <1%
Canada 1 <1%
Unknown 105 95%

Demographic breakdown

Readers by professional status Count As %
Researcher 19 17%
Student > Master 14 13%
Student > Bachelor 13 12%
Student > Ph. D. Student 13 12%
Professor 10 9%
Other 22 20%
Unknown 20 18%
Readers by discipline Count As %
Medicine and Dentistry 41 37%
Agricultural and Biological Sciences 19 17%
Biochemistry, Genetics and Molecular Biology 13 12%
Psychology 3 3%
Neuroscience 3 3%
Other 10 9%
Unknown 22 20%

Attention Score in Context

This research output has an Altmetric Attention Score of 2. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 28 December 2015.
All research outputs
#12,051,505
of 20,639,027 outputs
Outputs from International Journal of Chronic Obstructive Pulmonary Disease
#1,110
of 2,177 outputs
Outputs of similar age
#79,292
of 149,475 outputs
Outputs of similar age from International Journal of Chronic Obstructive Pulmonary Disease
#9
of 18 outputs
Altmetric has tracked 20,639,027 research outputs across all sources so far. This one is in the 40th percentile – i.e., 40% of other outputs scored the same or lower than it.
So far Altmetric has tracked 2,177 research outputs from this source. They typically receive a little more attention than average, with a mean Attention Score of 6.2. This one is in the 47th percentile – i.e., 47% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 149,475 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 45th percentile – i.e., 45% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 18 others from the same source and published within six weeks on either side of this one. This one has gotten more attention than average, scoring higher than 55% of its contemporaries.